文献速递妇科

复发性成人型颗粒细胞瘤微创与开腹肿瘤细胞减灭术的生存结局比较

Survival outcomes comparing minimally invasive versus open cytoreductive surgery in recurrent adult-type granulosa cell tumors.
PubMed 文献 · Am J Obstet Gynecol · 2025-01-15

本研究为回顾性队列研究,纳入MD Anderson罕见妇科恶性肿瘤登记库中截至2024年4月的108例首次复发并接受二次肿瘤细胞减灭术的成人型颗粒细胞瘤患者,其中开腹组78例(72%)、微创组30例(28%)。两组总生存期(中位166个月 vs 94个月,P=.27)及无进展生存期(中位26个月 vs 21个月,P=.42)均无显著差异,调整关键变量后无进展生存差异仍不显著。作者认为微创手术可考虑用于经过仔细选择的复发性成人型颗粒细胞瘤患者。

要点

  • 开腹组与微创组的中位总生存期分别为166个月和94个月,差异无统计学意义(P=.27)。
  • 开腹组与微创组首次复发后的中位无进展生存期分别为26个月和21个月,差异无统计学意义(P=.42)。
  • 作者认为,对于经过仔细选择的复发性成人型颗粒细胞瘤患者,可考虑微创手术。

核心结论

  • 在首次复发的成人型颗粒细胞瘤患者中,开腹二次肿瘤细胞减灭术与微创手术相比未获得更优的结局。
  • 作者认为,对于经过仔细选择的复发性成人型颗粒细胞瘤患者,可考虑微创手术。
  • 未来需要针对影响手术入路选择的患者因素开展研究。

研究设计与样本

  • 本研究为回顾性队列研究,纳入MD Anderson罕见妇科恶性肿瘤登记库中截至2024年4月登记的成人型颗粒细胞瘤患者。
  • 纳入标准为至少有一次记录的复发并接受二次肿瘤细胞减灭术作为治疗计划的一部分。
  • 排除标准为手术在2000年1月1日之前进行或手术非经腹进行。
  • 共识别485例成人型颗粒细胞瘤患者,其中108例符合纳入标准。
  • 手术复杂性根据所施行的手术分为低、中、高三个等级。

主要发现

  • 开腹组78例(72%),微创组30例(28%)。
  • 开腹组与微创组在初始分期、自报种族或诊断时年龄等基线特征上无差异。
  • 微创组手术时年龄显著低于开腹组,中位年龄分别为42岁和49岁(P=.03)。
  • 开腹组中33%的手术为中复杂度、4%为高复杂度,微创组分别为7%和0%(P=.004)。
  • 达到理想肿瘤细胞减灭的比例在开腹组为85%、微创组为88%,两组无差异(P=.68)。

临床怎么用

  • 作者认为,对于经过仔细选择的复发性成人型颗粒细胞瘤患者,可考虑微创手术。
  • 作者提出,未来需要针对影响手术入路选择的患者因素开展研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adult-type granulosa cell tumors are a rare form of ovarian cancer, 30% of which will recur. Cytoreductive surgery is often performed at the time of a first recurrence, but little is known about the impact of open versus minimally invasive surgical approaches on survival outcomes. OBJECTIVE: To examine associations between surgical approach, clinical variables, and survival outcomes among patients with adult-type granulosa cell tumors who underwent cytoreductive surgery at the time of first recurrence. STUDY DESIGN: This is a retrospective cohort study of patients with adult-type granulosa cell tumors enrolled in the MD Anderson Rare Gynecologic Malignancy Registry as of April 2024. Included patients had at least one documented recurrence and underwent secondary cytoreductive surgery as part of their treatment plan. Patients were excluded if surgery was performed prior to January 1, 2000, or if surgery was not intraabdominal. Demographics and clinical variables were compared using descriptive statistics. Surgical complexity was classified as either low, intermediate, or high based on procedures performed. Progression-free and overall survival outcomes were stratified by surgical approach and estimated using Kaplan-Meier curves. A multivariable Cox proportional hazards model was used to adjust progression-free survival at time of first recurrence for age, year of surgery, and extent of disease. RESULTS: Four hundred eighty-five patients with adult granulosa cell tumors were identified, 108 met inclusion criteria. Seventy-eight (72%) had open and 30 (28%) had minimally invasive secondary cytoreductive surgery. Baseline characteristics, including initial stage, self-identified race, or age at diagnosis, did not differ between open and minimally invasive surgery groups. Patients undergoing minimally invasive surgery were significantly younger at the time of surgery than the open group, with a median age of 42 vs 49, respectively (P=.03). For the open group, 33% of surgeries were considered intermediate complexity and 4% high complexity, compared to 7% and 0% in the minimally invasive surgery group, respectively (P=.004). There was no difference in achieving optimal cytoreduction, 85% in the open group and 88% in the minimally invasive surgery group (P=.68). Following secondary cytoreductive surgery, there was no difference in overall survival, median overall survival of 166 months in the open group and 94 months in the minimally invasive group (P=.27), or progression-free survival after first recurrence, 26 months in the open group compared to 21 months in the minimally invasive group (P=.42). The difference in progression-free survival after the first recurrence remained nonsignificant after adjustment for key potential variables, including age, surgical approach, year of surgery, and extent of disease. There was no difference in incisional or port site recurrences at the time of second recurrence among those undergoing open (8.3%) compared to minimally invasive surgery (7.4%) at time of first recurrence (P=.89). CONCLUSION: In patients with a first recurrence of adult-type granulosa cell tumors, open secondary cytoreductive surgery did not achieve superior outcomes compared to surgery via a minimally invasive approach. Minimally invasive surgery should be considered for carefully selected patients with recurrent adult-type granulosa cell tumors. Future research is needed on patient factors important to the selection of surgical approach in this setting.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Brodsky AL, Flores Legarreta A, How JA, et al. Survival outcomes comparing minimally invasive versus open cytoreductive surgery in recurrent adult-type granulosa cell tumors. Am J Obstet Gynecol. 2025. PMID: 39824329. doi:10.1016/j.ajog.2025.01.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。